Financhill
Sell
42

IMRX Quote, Financials, Valuation and Earnings

Last price:
$6.73
Seasonality move :
-21.18%
Day range:
$6.57 - $6.87
52-week range:
$1.10 - $10.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
323.21x
P/B ratio:
1.91x
Volume:
1.3M
Avg. volume:
1.2M
1-year change:
208.72%
Market cap:
$434.6M
Revenue:
--
EPS (TTM):
-$1.78

Earnings Data

Next earnings date for IMRX
Mar 19
2026
Most recent earnings per share
-$0.38
Beat by $0.01
(Nov 12/2025)
Consensus Estimate
-$0.39
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/19/2026 Q4 -- -- -- -$0.31 --
11/12/2025 Q3 -- -- -$0.38 -$0.39 $0.01
08/13/2025 Q2 -- -- -$0.40 -$0.40 -$0.00
05/06/2025 Q1 -- -- -$0.42 -$0.59 $0.16
03/20/2025 Q4 -- -- -$0.58 -$0.45 -$0.14
11/13/2024 Q3 -- -- -$0.49 -$0.55 $0.06
08/06/2024 Q2 -- -- -$0.47 -$0.53 $0.05
05/07/2024 Q1 -- -- -$0.49 -$0.50 $0.02
03/01/2024 Q4 -- -- -$0.52 -$0.48 -$0.04
11/09/2023 Q3 -- -- -$0.43 -$0.49 $0.06
08/03/2023 Q2 -- -- -$0.43 -- --
05/04/2023 Q1 -- -- -$0.51 -- --
03/06/2023 Q4 -- $500 -$0.50 -- --
11/10/2022 Q3 -- $38.4K -$0.49 -- --
08/10/2022 Q2 -- $94.4K -$0.44 -- --
05/10/2022 Q1 -- $183.7K -$0.49 -- --
03/10/2022 Q4 -- $189.6K -$0.41 -- --
11/09/2021 Q3 -- $482.1K -$0.33 -- --
09/09/2021 Q2 -- $660K -$0.31 -- --
03/31/2021 Q1 -- $748.2K -$0.24 -- --
12/31/2020 Q4 -- $665.1K -$0.43 -- --
09/30/2020 Q3 -- $682.6K -$0.17 -- --
06/30/2020 Q2 -- $480.8K -$0.14 -- --
03/31/2020 Q1 -- $483K -$0.13 -- --

Immuneering Corp. Earnings Questions

  • How Much did Immuneering Corp. Generate in Revenue Last Quarter?

    Immuneering Corp. reported -- worth of top line sales in its most recent quarter.

  • Did Immuneering Corp. Beat Earnings Last Quarter?

    Immuneering Corp. announced earnings per share of -$0.38 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Immuneering Corp. Profitable?

    Immuneering Corp. reported -$86.2K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Immuneering Corp. EPS Next Year?

    Immuneering Corp.'s earnings are forecast to decrease from -$2.04 per share to -$1.42 per share next year representing a decrease of -30.41%.

  • When is Immuneering Corp.'s Earnings Date?

    Immuneering Corp.'s next earnings date is March 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock